Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Apr;63(4):1380–1386. doi: 10.1128/iai.63.4.1380-1386.1995

Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.

M Soell 1, M Diab 1, G Haan-Archipoff 1, A Beretz 1, C Herbelin 1, B Poutrel 1, J P Klein 1
PMCID: PMC173162  PMID: 7890398

Abstract

In order to examine the possible implication of capsular polysaccharide (CP) types 5 and 8 (CP5 and CP8) from Staphylococcus aureus in the pathological mechanism associated with staphylococcal infections, we tested the immunomodulatory effects of CP5 and CP8 on human epithelial KB cells, endothelial cells, and monocytes. Using biotinylated CP5 and CP8, we provide evidence that both CPs bind to KB cells, endothelial cells, and monocytes in a dose- and calcium-dependent manner through specific interactions. These results were confirmed by competition experiments using soluble cell extracts. Furthermore, we show that CPs bind to identical cell membrane receptors on all three types of human cells and that human normal serum contains a factor(s) which inhibits the binding of both CPs to human KB cells, endothelial cells, and monocytes. The ability of CP5 and CP8 to stimulate the production of cytokines by the human cells was then examined. CP5 and CP8 trigger KB cells to produce interleukin-8 (IL-8); endothelial cells to produce IL-8 and IL-6; and monocytes to produce IL-8, IL-6, IL-1 beta, and tumor necrosis factor alpha. The release of cytokines by all three types of cells is time dependent and dose dependent, and the tumor necrosis factor alpha production by monocytes is not affected by the addition of polymyxin B. We further confirm that human normal serum inhibits the immunomodulatory effects of both polysaccharides on each kind of cell. These results confirm that S. aureus CPs act as bacterial adhesins having immunomodulatory effects for human cells.

Full Text

The Full Text of this article is available as a PDF (252.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansel J., Perry P., Brown J., Damm D., Phan T., Hart C., Luger T., Hefeneider S. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol. 1990 Jun;94(6 Suppl):101S–107S. doi: 10.1111/1523-1747.ep12876053. [DOI] [PubMed] [Google Scholar]
  2. Arbeit R. D., Nelles M. J. Capsular polysaccharide antigenemia in rats with experimental endocarditis due to Staphylococcus aureus. J Infect Dis. 1987 Feb;155(2):242–246. doi: 10.1093/infdis/155.2.242. [DOI] [PubMed] [Google Scholar]
  3. Benabdelmoumene S., Dumont S., Petit C., Poindron P., Wachsmann D., Klein J. P. Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect Immun. 1991 Sep;59(9):3261–3266. doi: 10.1128/iai.59.9.3261-3266.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bone R. C. Gram-positive organisms and sepsis. Arch Intern Med. 1994 Jan 10;154(1):26–34. [PubMed] [Google Scholar]
  5. Boutonnier A., Nato F., Bouvet A., Lebrun L., Audurier A., Mazie J. C., Fournier J. M. Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol. 1989 May;27(5):989–993. doi: 10.1128/jcm.27.5.989-993.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dentener M. A., Von Asmuth E. J., Francot G. J., Marra M. N., Buurman W. A. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J Immunol. 1993 Oct 15;151(8):4258–4265. [PubMed] [Google Scholar]
  7. Espevik T., Otterlei M., Skjåk-Braek G., Ryan L., Wright S. D., Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol. 1993 Jan;23(1):255–261. doi: 10.1002/eji.1830230140. [DOI] [PubMed] [Google Scholar]
  8. Fargeas C. A., Scholler M., Pini A., Wachsmann D., Poindron P., Klein J. P. Purification and partial characterization of rat macrophage Fc receptor and binding factor for IgA. Biochim Biophys Acta. 1990 Mar 1;1037(3):344–350. doi: 10.1016/0167-4838(90)90036-f. [DOI] [PubMed] [Google Scholar]
  9. Hedges S., Svensson M., Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun. 1992 Apr;60(4):1295–1301. doi: 10.1128/iai.60.4.1295-1301.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hmama Z., Mey A., Normier G., Binz H., Revillard J. P. CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae. Infect Immun. 1994 May;62(5):1520–1527. doi: 10.1128/iai.62.5.1520-1527.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ikejima T., Okusawa S., van der Meer J. W., Dinarello C. A. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells. J Infect Dis. 1988 Nov;158(5):1017–1025. doi: 10.1093/infdis/158.5.1017. [DOI] [PubMed] [Google Scholar]
  12. Karakawa W. W., Sutton A., Schneerson R., Karpas A., Vann W. F. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun. 1988 May;56(5):1090–1095. doi: 10.1128/iai.56.5.1090-1095.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klein-Soyer C., Beretz A., Millon-Collard R., Abecassis J., Cazenave J. P. A simple in vitro model of mechanical injury of confluent cultured endothelial cells to study quantitatively the repair process. Thromb Haemost. 1986 Oct 21;56(2):232–235. [PubMed] [Google Scholar]
  14. Kuwano K., Akashi A., Matsu-ura I., Nishimoto M., Arai S. Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus. Infect Immun. 1993 May;61(5):1700–1706. doi: 10.1128/iai.61.5.1700-1706.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee J. C., Takeda S., Livolsi P. J., Paoletti L. C. Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus. Infect Immun. 1993 May;61(5):1853–1858. doi: 10.1128/iai.61.5.1853-1858.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lynn W. A., Golenbock D. T. Lipopolysaccharide antagonists. Immunol Today. 1992 Jul;13(7):271–276. doi: 10.1016/0167-5699(92)90009-V. [DOI] [PubMed] [Google Scholar]
  17. Malhotra R., Thiel S., Reid K. B., Sim R. B. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med. 1990 Sep 1;172(3):955–959. doi: 10.1084/jem.172.3.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moreau M., Richards J. C., Fournier J. M., Byrd R. A., Karakawa W. W., Vann W. F. Structure of the type 5 capsular polysaccharide of Staphylococcus aureus. Carbohydr Res. 1990 Jul 1;201(2):285–297. doi: 10.1016/0008-6215(90)84244-o. [DOI] [PubMed] [Google Scholar]
  19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  20. Nakamura H., Yoshimura K., Jaffe H. A., Crystal R. G. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem. 1991 Oct 15;266(29):19611–19617. [PubMed] [Google Scholar]
  21. Otterlei M., Sundan A., Skjåk-Braek G., Ryan L., Smidsrød O., Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun. 1993 May;61(5):1917–1925. doi: 10.1128/iai.61.5.1917-1925.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parsonnet J., Gillis Z. A. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1. J Infect Dis. 1988 Nov;158(5):1026–1033. doi: 10.1093/infdis/158.5.1026. [DOI] [PubMed] [Google Scholar]
  23. Poutrel B., Gilbert F. B., Lebrun M. Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains. Clin Diagn Lab Immunol. 1995 Mar;2(2):166–171. doi: 10.1128/cdli.2.2.166-171.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ruoslahti E., Vuento M., Engvall E. Interaction of fibronectin with antibodies and collagen in radioimmunoassay. Biochim Biophys Acta. 1978 Jun 21;534(2):210–218. doi: 10.1016/0005-2795(78)90003-x. [DOI] [PubMed] [Google Scholar]
  25. Schuerer-Maly C. C., Eckmann L., Kagnoff M. F., Falco M. T., Maly F. E. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology. 1994 Jan;81(1):85–91. [PMC free article] [PubMed] [Google Scholar]
  26. Sheagren J. N. Staphylococcus aureus. The persistent pathogen (first of two parts). N Engl J Med. 1984 May 24;310(21):1368–1373. doi: 10.1056/NEJM198405243102107. [DOI] [PubMed] [Google Scholar]
  27. Sompolinsky D., Samra Z., Karakawa W. W., Vann W. F., Schneerson R., Malik Z. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol. 1985 Nov;22(5):828–834. doi: 10.1128/jcm.22.5.828-834.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stevenson H. C. Isolation of human mononuclear leukocyte subsets by countercurrent centrifugal elutriation. Methods Enzymol. 1984;108:242–249. doi: 10.1016/s0076-6879(84)08087-3. [DOI] [PubMed] [Google Scholar]
  29. Takahashi T., Nishihara T., Ishihara Y., Amano K., Shibuya N., Moro I., Koga T. Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans. Infect Immun. 1991 Jan;59(1):18–23. doi: 10.1128/iai.59.1.18-23.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Timmerman C. P., Mattsson E., Martinez-Martinez L., De Graaf L., Van Strijp J. A., Verbrugh H. A., Verhoef J., Fleer A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun. 1993 Oct;61(10):4167–4172. doi: 10.1128/iai.61.10.4167-4172.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wakabayashi G., Gelfand J. A., Jung W. K., Connolly R. J., Burke J. F., Dinarello C. A. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest. 1991 Jun;87(6):1925–1935. doi: 10.1172/JCI115218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. van de Wiel P. A., Witvliet M. H., Evenberg D., Derks H. J., Beuvery E. C. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide. Vaccine. 1987 Mar;5(1):33–38. doi: 10.1016/0264-410x(87)90006-5. [DOI] [PubMed] [Google Scholar]
  33. von Asmuth E. J., Dentener M. A., Bazil V., Bouma M. G., Leeuwenberg J. F., Buurman W. A. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin. Immunology. 1993 Sep;80(1):78–83. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES